Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Penumbra Inc (PEN) USD0.001

Sell:$291.01 Buy:$291.55 Change: $2.36 (0.82%)
Market closed |  Prices as at close on 16 September 2021 | Switch to live prices |
Sell:$291.01
Buy:$291.55
Change: $2.36 (0.82%)
Market closed |  Prices as at close on 16 September 2021 | Switch to live prices |
Sell:$291.01
Buy:$291.55
Change: $2.36 (0.82%)
Market closed |  Prices as at close on 16 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.

Contact details

Address:
1 Penumbra
ALAMEDA
94502-7676
United States
Telephone:
+1 (510) 9952486
Website:
www.penumbrainc.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PEN
ISIN:
US70975L1070
Market cap:
$10.57 billion
Shares in issue:
36.58 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Adam Elsesser
    Chairman of the Board, Chief Executive Officer
  • Maggie Yuen
    Chief Financial Officer
  • James Pray
    President, International
  • Johanna Roberts
    Executive Vice President, General Counsel, Secretary
  • Lynn Rothman
    Executive Vice President, Chief Business Officer
  • Lambert Shiu
    Chief Accounting Officer
  • Arani Bose
    Chief Innovator, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.